Scanoma is a medical app for tracking skin lesions and requesting remote dermatologist reviews on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
4.6
2k reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
The service removes the time-cost of in-person dermatology visits for users seeking immediate peace of mind regarding skin changes.
For Individuals seeking to monitor skin changes for early detection of potential issues and those requiring remote access to dermatological advice.
What does it look like?
Key features
Visual timeline tool for side-by-side comparison of skin spots over time, building a longitudinal health record that increases switching costs.
Remote review of user-submitted skin images by licensed human doctors, generating revenue via per-consultation fees.
Location-based monitoring of UV levels with push notifications to increase daily app open frequency.
How much does it cost?
Monetization relies on a transactional service model where the app is free to use, but professional medical feedback is gated behind a per-consultation fee.
Velocity
Maintenance developmentperformanceUX improvementsShow more...
With only two releases identified in the recent window, the app maintains a maintenance-level cadence of approximately one update every 6-8 weeks. Development is currently focused on stability, performance, and minor UX refinements rather than new feature expansion. The latest release specifically addressed notification behavior and sign-in recovery, indicating a focus on core utility maintenance.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate direct access to medical professionals provides peace of mind for users with health anxiety and early detection of concerning skin lesions helps users seek timely in-person medical intervention, but report paywall implementation for initial scans frustrates users who previously accessed free ai assessment tools.
How are ratings & reviews evolving?
What users say, by theme
- Direct access to medical professionals provides peace of mind for users with health anxiety
- Early detection of concerning skin lesions helps users seek timely in-person medical intervention
- Paywall implementation for initial scans frustrates users who previously accessed free AI assessment tools
60 of 99 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for scanoma - mole check
How's the Medical market?
Scanoma maintains a 4.71 rating on iOS with 1,347 ratings, positioning it as a niche utility in the Medical category. The reliance on per-consultation fees rather than subscriptions creates a transactional barrier that differentiates it from broader health-tracking apps.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for scanoma - mole check
Where is it heading?
The medical diagnostic market is shifting toward high-fidelity remote services, and Scanoma's reliance on human-verified reports positions it well for long-term trust. However, the lack of recent feature expansion and persistent camera-related complaints suggest a maintenance-mode risk that could erode the current rating baseline if not addressed.
- User backlash regarding the removal of free AI tools suggests that the current monetization pivot is poorly aligned with user expectations.
- The high rating on iOS suggests that the core value proposition of remote dermatologist access remains a strong retention driver for the target audience.
The SWOT
- Mole Mapper's longitudinal health record increases switching costs
- Native camera and gallery uploads would improve diagnostic image quality
Next best moves
Integrate native camera and gallery uploads because the custom camera tool produces blurry images → improve diagnostic accuracy
The counter-intuitive read
The transition to a paid-only consultation model is…
Read the full takeSince the last report: Scanoma has transitioned from a negative to a mixed outlook, with the analyst now framing the controversial paywall as a necessary component for medical liability rather than a purely negative monetization friction.
Bottom line
Integrating native camera support would resolve the primary diagnostic friction point, which currently drives negative sentiment and limits the accuracy of the professional consultations that generate revenue.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated